Earnings History Data for Mustang Bio (MBIO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Mustang Bio

Mustang Bio, Inc. a subsidiary of Fortress Biotech, Inc., is a clinical?stage biopharmaceutical company. It focused on the development and commercialization of novel cancer immunotherapy products designed to leverage the patient's own immune system to eliminate cancer cells. Mustang Bio, Inc. is based in New York, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-11-2024	AH		MBIO	Mustang Bio	9.00	-0.04	-0.13	0.00		0.2546	0.0 (-0.16%)	0.26	0.0 (1.96%)	0.13 - 1.73	1,418,681	1,770,000	72,404
Mustang Bios MB-108 receives FDA orphan drug status for glioma treatment [2024-11-08 06:36AM] Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma [Nov-07-24 08:30AM]
11-03-2024	AH		MBIO	Mustang Bio	13.00	-0.71	-1.68	0.00	Mustang Bio GAAP EPS of -$6.00 beats by $0.67 [3/11/2024 4:56 PM]	1.08	-0.08 (-6.90%)	1.10	-0.06 (-5.17%)	1.06 - 8.17	116,505	510,000	1,989
Mustang Bio GAAP EPS of -$6.00 beats by $0.67 [3/11/2024 4:56 PM]
14-08-2023	AH		MBIO	Mustang Bio	39.00	-2.00	-2.07	0.00	Mustang Bio GAAP EPS of -$2.00 misses by $0.19 [8/14/2023 5:13 PM]	3.78	-0.25 (-6.20%)	3.95	-0.08 (-1.99%)	2.82 - 11.60	57,514	20,000	361
Mustang Bio GAAP EPS of -$2.00 misses by $0.19 [8/14/2023 5:13 PM]
11-08-2022	AH	4:05 PM ET (Aug 11)	MBIO	Mustang Bio	72.00	-0.19	-0.21	0.00	Mustang Bio GAAP EPS of -$0.19 beats by $0.02 [8/11/2022 5:23 PM]	0.7550	0.02 (2.29%)	0.74	0.0 (0.00%)	0.51 - 3.09	651,470	660,000	630
Mustang Bio GAAP EPS of -$0.19 beats by $0.02 [8/11/2022 5:23 PM] Mustang Bio Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights [Aug-11-22 04:05PM]
12-05-2022	AH		MBIO	Mustang Bio	70.00	-0.20	-0.18	0.00	Mustang Bio GAAP EPS of -$0.20 [5/12/2022 4:46 PM]	0.70	0.04 (6.84%)	0.68	0.02 (3.79%)	0.62 - 4.06	1,173,458	750,000	29,775
Mustang Bio GAAP EPS of -$0.20 [5/12/2022 4:46 PM] Mustang Bio Reports First Quarter 2022 Financial Results and Recent Corporate Highlights [May-12-22 04:05PM] Mustang Bio Announces Results from Follicular Lymphoma Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted CAR T Therapy, Selected for Oral Presentation at European Hematology Association 2022 Hybrid Congress [May-12-22 10:38AM]
14-05-2021	AH		MBIO	Mustang Bio, Inc.	244.00	-0.19	-0.20	0.00	Mustang Bio EPS in-line [5/14/2021 4:36 PM]	2.85	0.06 (1.97%)	2.77	-0.02 (-0.72%)	2.42 - 5.22	1,267,633	1,600,000	13,402
Mustang Bio Reports First Quarter 2021 Financial Results and Recent Corporate Highlights [May-14-21 04:30PM]
06-11-2020	AH		MBIO	Mustang Bio, Inc.	165.00	-0.23	-0.26	0.00	Mustang Bio EPS beats by $0.02 [11/6/2020 4:23 PM]	2.76	0.06 (2.04%)	2.76	0.06 (2.22%)	1.78 - 4.85	1,409,288	1,431,612	33,177